National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

recombinant tissue plasminogen activator (ree-KOM-bih-nunt TIH-shoo plaz-MIN-oh-jen AK-tih-vay-tur)

 A form of tissue plasminogen activator that is made in the laboratory. It helps dissolve blood clots and is used to treat heart attacks, strokes, and clots in the lungs. It is also being studied in the treatment of cancer. It is a type of systemic thrombolytic agent. Also called Activase, Alteplase, and r-tPA.



Previous Definitions:recombinant fowlpox-CEA-MUC-1-TRICOM vaccine, recombinant fowlpox-TRICOM vaccine, recombinant human interleukin-2, recombinant human interleukin-11, recombinant human methionyl stem cell factor
Next Definitions:recombinant vaccinia-CEA-MUC-1-TRICOM vaccine, recombinant vaccinia-TRICOM vaccine, reconstructive surgeon, reconstructive surgery, recover

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov